Atlas Trials

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

Clinical trial NCT00577278 · COMPLETED

Trial details

NCT number
NCT00577278
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Versus Host DiseaseLeukemiaLymphoma
Start date
2007-10-03
Primary completion
2019-05-30
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.